tradingkey.logo
tradingkey.logo
Search

Haemonetics Corp

HAE
Add to Watchlist
85.540USD
+0.780+0.92%
Close 07-31 16:00ETQuotes delayed by 15 min
3.89BMarket Cap
41.47P/E TTM

HAE Financials

See Haemonetics Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Haemonetics Corp Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/1.08
Revenue / Forecast
--/327.89M
Period
FY2026 Earnings
Revenue(YoY)
1.33B
-1.97%
EPS(YoY)
2.06
-38.09%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-136.98%-0.44
28.24%0.96
22.29%0.81
-6.09%0.71
193.90%1.18
21.17%0.75
35.37%0.66
-7.24%0.75
-30.86%0.40
-5.65%0.62
--0.49
--0.81
--0.58
--0.65
----
----
----
----
----
----
----
Revenue
4.76%346.35M
-2.75%338.97M
-5.27%327.31M
-4.40%321.39M
-3.70%330.60M
3.66%348.54M
8.59%345.51M
7.98%336.17M
12.77%343.29M
10.14%336.25M
6.96%318.18M
19.08%311.33M
14.87%304.42M
17.53%305.30M
24.01%297.49M
14.41%261.46M
17.76%265.00M
8.07%259.77M
14.52%239.90M
16.85%228.53M
----
Net Profit
-134.75%-20.15M
19.33%44.74M
14.34%38.68M
-11.32%34.03M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
201.64%29.38M
41.80%32.94M
123.46%33.20M
546.27%19.88M
188.23%9.74M
-27.13%23.23M
-69.11%14.86M
-142.31%-4.45M
----
Net Margin
-133.17%-5.82%
22.70%13.20%
20.70%11.82%
-7.24%10.59%
195.61%17.54%
15.78%10.76%
25.08%9.79%
-13.41%11.41%
-38.53%5.93%
-13.90%9.29%
--7.83%
--13.18%
--9.65%
--10.79%
----
----
----
----
----
----
----
Gross Margin
-1.47%54.22%
6.76%56.47%
8.20%56.04%
13.16%56.15%
11.49%55.03%
-0.10%52.89%
0.88%51.79%
-3.44%49.62%
1.33%49.36%
7.34%52.94%
--51.34%
--51.39%
--48.71%
--49.32%
----
----
----
----
----
----
----
Debt to assets ratio
2.28%51.11%
1.61%49.17%
3.38%50.15%
3.30%49.75%
35.82%49.97%
22.30%48.39%
28.00%48.51%
23.53%48.15%
-7.05%36.79%
-3.09%39.56%
--37.90%
--38.98%
--39.58%
--40.83%
----
----
----
----
----
----
----
Revenue
4.76%346.35M
-2.75%338.97M
-5.27%327.31M
-4.40%321.39M
-3.70%330.60M
3.66%348.54M
8.59%345.51M
7.98%336.17M
12.77%343.29M
10.14%336.25M
6.96%318.18M
19.08%311.33M
14.87%304.42M
17.53%305.30M
24.01%297.49M
14.41%261.46M
17.76%265.00M
8.07%259.77M
14.52%239.90M
16.85%228.53M
----
Operating profit
-22.65%54.02M
10.25%78.71M
24.89%81.10M
42.63%70.84M
40.17%69.84M
9.80%71.39M
9.82%64.94M
-19.34%49.67M
-10.01%49.83M
34.21%65.02M
18.57%59.13M
84.74%61.58M
40.08%55.37M
9.54%48.45M
66.00%49.87M
43.95%33.33M
9958.52%39.53M
1.30%44.23M
-12.24%30.04M
23.26%23.16M
----
Net Profit
-134.75%-20.15M
19.33%44.74M
14.34%38.68M
-11.32%34.03M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
201.64%29.38M
41.80%32.94M
123.46%33.20M
546.27%19.88M
188.23%9.74M
-27.13%23.23M
-69.11%14.86M
-142.31%-4.45M
----
Current assets
-10.71%834.88M
--943.67M
-5.88%899.68M
-6.69%913.16M
21.60%934.98M
----
10.41%955.90M
22.08%978.58M
-0.11%768.90M
8.31%764.98M
20.95%865.74M
16.55%801.61M
1.81%769.72M
-3.17%706.31M
2.37%715.79M
0.50%687.78M
9.01%756.03M
9.14%729.46M
-8.03%699.25M
-9.88%684.37M
14.89%693.55M
Total current liabilities
-51.12%282.60M
--539.87M
100.16%548.32M
104.33%531.41M
92.46%578.11M
----
3.68%273.95M
9.76%260.08M
19.29%300.38M
15.37%261.75M
0.78%264.21M
31.28%236.94M
-43.06%251.82M
-36.16%226.89M
-9.12%262.18M
-20.96%180.49M
74.47%442.27M
82.84%355.41M
-14.80%288.47M
-44.01%228.34M
-7.76%253.50M
Total assets
-2.24%2.40B
--2.49B
-3.29%2.44B
-3.10%2.46B
11.63%2.45B
----
25.55%2.53B
29.49%2.54B
13.48%2.20B
17.16%2.20B
7.84%2.01B
7.79%1.96B
4.04%1.93B
2.55%1.88B
3.53%1.87B
1.47%1.82B
2.19%1.86B
38.94%1.83B
27.03%1.80B
25.19%1.79B
43.63%1.82B
Total liabilities
-1.87%1.60B
--1.58B
-3.24%1.59B
-3.41%1.58B
31.93%1.63B
----
47.31%1.65B
49.01%1.64B
10.64%1.24B
14.07%1.26B
-1.63%1.12B
4.53%1.10B
0.59%1.12B
0.14%1.10B
3.01%1.14B
-6.00%1.05B
2.03%1.11B
83.77%1.10B
47.01%1.10B
35.47%1.12B
60.04%1.09B
Total equity
-2.99%796.32M
--911.45M
-3.38%849.17M
-2.55%882.30M
-14.49%820.84M
----
-1.66%878.85M
4.71%905.37M
17.35%959.96M
21.57%943.32M
22.59%893.66M
12.23%864.62M
9.15%818.00M
6.19%775.98M
4.36%729.01M
13.79%770.42M
2.43%749.42M
1.62%730.77M
4.59%698.55M
11.26%677.08M
24.62%731.67M
Net operating income
-39.14%70.94M
113.78%93.56M
128.01%111.32M
163.44%17.39M
81.89%116.56M
8204.81%43.77M
-50.75%48.82M
-243.67%-27.42M
-19.51%64.08M
-100.84%-540.00K
13.88%99.12M
-54.55%19.09M
16.99%79.61M
3.17%64.42M
100.27%87.04M
2599.58%41.99M
4298.84%68.05M
-5.82%62.43M
49.07%43.46M
-114.22%-1.68M
----
Net investment
-580.12%-86.61M
-69.63%-29.47M
-30.39%-30.47M
76.29%-33.00M
238.17%18.04M
93.54%-17.37M
7.03%-23.37M
-812.11%-139.20M
27.49%-13.06M
-636.81%-268.94M
19.10%-25.14M
73.78%-15.26M
47.83%-18.01M
-136.06%-36.50M
-51.40%-31.07M
-267.26%-58.21M
91.96%-34.51M
-61.38%-15.46M
-155.26%-20.52M
33.67%-15.85M
----
Net financing
32.98%-101.50M
47.32%2.03M
-2.34%-76.55M
-100.73%-2.44M
-138.50%-151.45M
-98.74%1.38M
-943.00%-74.80M
55901.34%333.69M
-3861.45%-63.50M
320.27%109.43M
72.08%-7.17M
97.44%-598.00K
81.71%-1.60M
-2341.28%-49.68M
-674.84%-25.69M
-1331.76%-23.39M
-102.03%-8.77M
98.64%-2.04M
94.85%-3.31M
-101.10%-1.63M
----

FAQs

What is the total revenue of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its total revenue reached 1.33B, with a year-on-year change of 1.36B.

What are the current assets of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its current assets were 834.88M, with a year-on-year change of -10.71.

What are the total assets of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its total assets of Haemonetics Corp were 2.40B, with a year-on-year change of -2.24.

What are the total liabilities of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its total liabilities of Haemonetics Corp were 1.60B, with a year-on-year change of -1.87.

What is the total equity of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its total equity of Haemonetics Corp was 796.32M, with a year-on-year change of -2.99.

What is the net operating income of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its net operating income of Haemonetics Corp was 288.69M, with a year-on-year change of 8.75.

What is the net investment of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its net investment of Haemonetics Corp was -179.55M, with a year-on-year change of -10.90.

What is the net financing of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its net financing of Haemonetics Corp was -178.46M, with a year-on-year change of -264.00.

What is the Earnings Per Share (EPS) of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its Earnings Per Share (EPS) was 2.06, with a year-on-year change of -38.09.

What is the net income of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its net income was 97.31M, with a year-on-year change of -41.97.

What is the net margin of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its net profit margin was 7.29, with a year-on-year change of -40.80.

What is the gross margin of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its gross margin was 55.70, with a year-on-year change of 5.96.

What is the debt-to-asset ratio of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its debt-to-asset ratio was 51.11, with a year-on-year change of 2.28.

What is the Return on Equity (ROE) of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its Return on Equity (ROE) was 12.03, with a year-on-year change of -36.10.

What is the Return on Assets (ROA) of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its Return on Assets (ROA) was 4.02, with a year-on-year change of -44.37.

What is the operating profit of Haemonetics Corp?

According to Haemonetics Corp's FY2026 earnings report, its operating profit was 288.69M, with a year-on-year change of 8.75.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.